SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,232.95 |
| Enterprise Value ($M) | 3,897.56 |
| Book Value ($M) | 700.56 |
| Book Value / Share | 10.93 |
| Price / Book | 6.04 |
| NCAV ($M) | 694.66 |
| NCAV / Share | 10.84 |
| Price / NCAV | 6.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.18 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 22.83 |
| Current Ratio | 22.83 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 726.49 |
| Assets | 732.38 |
| Liabilities | 31.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -149.49 |
| Net Income | -126.22 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -99.74 |
| Cash from Investing | -143.53 |
| Cash from Financing | 336.85 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Bain Capital Life Sciences Fund II, L.P. | 4.10 | 0.00 | |
| 13G/A | Paradigm Biocapital Advisors LP | 6.70 | 14.17 | |
| 13G/A | Fairmount Funds Management LLC | 3.40 | -30.99 | |
| 13G | Vanguard Group Inc | 5.72 | ||
| 13G/A | Flynn James E | 35.01 | 0.02 | |
| 13G/A | Fmr Llc | 14.94 | 14.51 | |
| 13G | Perceptive Advisors Llc | 5.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 29,206 | 175,153 | 16.67 | |
| 50,023 | 222,770 | 22.45 | |
| 102,955 | 151,970 | 67.75 | |
| 94,715 | 188,000 | 50.38 | |
| 68,380 | 154,223 | 44.34 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NEOG – Neogen Corporation | NKTX – Nkarta, Inc. |
| NMRA – Neumora Therapeutics, Inc. | NVAX – Novavax, Inc. |
| NXTC – NextCure, Inc. |
Financial data and stock pages provided by
Fintel.io